Genetic alterations in human pancreatic cancer

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 4, Issue 3, 1997, Pages 283-290

  Murakami, Yoshinori ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

c K ras gene; Hereditary predisposition; Oncogene; Pancreatic cancer; Tumor suppressor gene

Indexed keywords

EID: 0000581811     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02489026     Document Type: Article

References (25)

1. Kakizoe T (1995) Figures on cancer in Japan - 1995. Foundation for promotion of cancer research, Tokyo
2. Weinberg RA (1996) How cancer arises. Sci Am 275:62-70
3. Nishimura S, Sekiya T (1987) Human cancer and cellular oncogenes. Biochem J 243:313-327
4. Almoquesta C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554
5. Smit VTHBM, Boot AJM, Amit AMM, Fleuren GJ, Cornelisse CJ, Bos JL (1987) K-ras codon 12 mutations occur very frequently in panccreatic adenocarcinomas. Nucleic Acids Res 16:7773-7782
6. Grunewald K, Lyons J, Frohlich A, Feichtinger H, Weger RA, Schwab G, Janssen JWG, Bartram CR (1989) High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 43:1037-1041
7. Mariyama M, Kishi K, Nakamura K, Obata H, Nishimura S (1989) Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 80:622-626
8. Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall PA, Kloppel G (1992) Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 102:230-236
9. Motojima K, Urano T, Nagata Y, Shiku H, Tsunoda T, Kanematsu T (1991) Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. Am J Gastroenterol 86:1784-1788
10. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR (1992) AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/ threonine kinases, is amplified in human ovarian carciomas. Proc Natl Acad Sci USA 89:9267-9271
11. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR (1996) Amplfication of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sei USA 93:3636-3641
12. Miwa W, Yasuda J, Murakami Y, Yashima K, Sugano K, Sekine T, Kono A, Egawa S, Yamaguchi K, Hayashizaki Y, Sekiya T (1996) Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. Biochem Biophys Res Commun 225:968-974
13. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736
14. Ebert M, Yokoyama M, Friess H, Kobrin MS, Buchler MW, Korc M (1995) Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int J Cancer 62:529-535
15. Lemoine NR, Hughes CM, Barton CM, Poulsom R, Jeffery RE, Kloppel G, Hall PA, Gullick WJ (1992) The epidermal growth factor receptor in human pancreatic cancer. J Pathol 166:7-12
16. Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Kloppel G (1992) The erbB-3 gene in human pancreatic cancer. J Pathol 168:269-723
17. Lei S, Appert HE, Nakata B, Domenico DR, Kim K, Howard JM (1995) Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival. Int J Pancreatol 17:15-21
18. Okada N, Ohshio G, Yamaki K, Imamura T, Imamura M (1995) Elevated serum c-erbB-2 protein levels in patients with pancreatic cancer: Correlation to metastasis and shorter survival. Oncolony 52:392-396
19. Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ, Lemoine NR (1990) The c-erb B-2 proto-oncogene in human pancreatic cancer. J Pathol 161:195-200
20. Di Renzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR (1995) Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55:1129-1138
21. Ebert M, Yokoyama M, Friess H, Buchler MW, Korc M (1994) Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 54:5775-5778
22. Shibata D, Almoguera C, Forrester K, Dunitz J, Martin SE, Cosgrove MM, Perucho M, Arnheim N (1989) Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Science 230:1242-1246
23. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE (1994) Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 54:3568-3573
24. Tada M, Omata M, Kawai S, Saisho H, Ohio M, Saiki R, Sninsky JJ (1993) Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 53:2472-2474
25. Watanabe H, Sawabu N, Ohta H, Satomura Y, Yamakawa O, Motoo Y, Okai T, Takahashi H, Wakabayashi T (1993) Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn J Cancer Res 84:961-965